Laddar...
Clinical application of targeted next-generation sequencing for colorectal cancer patients: a multicentric Belgian experience
International guidelines made RAS (KRAS and NRAS) status a prerequisite for the use of anti-EGFR agents for metastatic colorectal cancer (CRC) patients. Daily, new data emerges on the theranostic and prognostic role of molecular biomarkers; this is a strong incentive for a validated, sensitive, and...
Sparad:
| I publikationen: | Oncotarget |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Impact Journals LLC
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5945518/ https://ncbi.nlm.nih.gov/pubmed/29755687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25099 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|